TAK

#480
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
17.7543 USD
-0.62%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
17.7100
17.7550
Rango anual
12.9900
18.8950
Cambio diario
-0.62%
Variación mensual
-3.61%
Variación en los últimos 6 meses
+25.16%
Cambio anual
+25.16%
Cierres anteriores
17.8650
Abrir
17.7150
Bid
Ask
Mínimo
17.7100
High
17.7550
Volumen
75
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 27.657 B
  • Employee 47 K
  • Founded N/A
  • CEO Christophe WeberChristophe Weber
  • Website www.takeda.com
  • Headquarter Japan
  • FIGI BBG000LF8708
  • Industry Fabricantes de medicamentos — especializados y genéricos

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Noticias